Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients-Reference-Cited by-同舟云学术

Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients

Published:2014-03-10 Issue:3 Volume:19 Page:3038-3054
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Fortunato Orazio,Boeri Mattia,Verri Carla,Conte Davide,Mensah Mavis,Suatoni Paola,Pastorino Ugo,Sozzi Gabriella

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/19/3/3038/pdf

Reference48 articles.

1. Cancer statistics, 2013

2. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results

3. Lung cancer screening

4. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)

5. Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma;Aging;2024-06-10

2. Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification;PLOS ONE;2024-02-29

3. Advancement in Machine Learning: A Strategic Lookout from Cancer Identification to Treatment;Archives of Computational Methods in Engineering;2023-01-20

4. MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults;International Journal of Molecular Sciences;2022-11-13

5. Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC;Frontiers in Immunology;2022-09-20